Prestige Biologics to make KOSDAQ debut in March

Prestige Biologics to make KOSDAQ debut in March
Posted : 2021-02-19 17:28
Updated : 2021-02-19 17:30
Prestige Biologics CEO Yang Jae-young speaks during a press conference at the Conrad Seoul in Yeouido, Seoul, Friday. Courtesy of Prestige Biologics
By Anna J. Park
Prestige Biologics, a Korea-headquartered contract development and manufacturing organization (CDMO) business, is set to debut on the tech-heavy KOSDAQ next month.
Founded in 2015, Prestige Biologics has focused on manufacturing and developing biologic drugs, particularly biosimilars ― biologic drugs whose patents have expired.
During a press conference Friday in Yeouido, the bio company said it plans to raise 63.9 billion won ($57.7 million) by offering 7.35 million in shares through an initial public offering (IPO).

Related Keywords

Osong ,Kyongsang Bukto ,South Korea ,Seoul ,Soult Ukpyolsi ,Yang Jae Young , ,Prestige Biologics ,Conrad Seoul ,Asset Daewoo ,North Chungcheong Province ,Singapore Based Prestige ,Prestige Biopharma ,Cdmo ,Kosdaq ,Ipo ,தெற்கு கொரியா ,சியோல் ,யாங் ஜே இளம் ,ப்ரெஸ்டீஜ் உயிரியல் ,கான்ராட் சியோல் ,சொத்து டேவூ ,சிங்கப்பூர் அடிப்படையிலானது ப்ரெஸ்டீஜ் ,கதிமோ ,இப்போ ,